Skip to main content
. 2017 Sep 19;7(1):17–26. doi: 10.1007/s13566-017-0328-1

Table 1.

Baseline characteristics of patients with painful spinal metastases, treated with a PA or an APPA technique

n Entire cohort Spinal patients PA APPA Difference PA versus APPAa
1157 343 250 93
Primary tumor n.s.
 Breast cancer 451 (39%) 145 (42%) 110 (44%) 35 (38%)
 Prostate cancer 267 (23%) 83 (24%) 63 (25%) 20 (22%)
 Lung cancer 287 (25%) 68 (20%) 48 (19%) 20 (22%)
 Other 152 (13%) 47 (14%) 29 (12%) 18 (19%)
Age n.s.
 ≤ 65 years 565 (49%) 167 (49%) 120 (48%) 47 (51%)
 > 65 years 592 (51%) 176 (51%) 130 (52%) 46 (50%)
Gender n.s.
 Male 624 (54%) 178 (52%) 125 (50%) 53 (57%)
 Female 533 (46%) 165 (48%) 125 (50%) 40 (43%)
KPS n.s.
 90–100 221 (19%) 67 (20%) 47 (19%) 20 (22%)
 70–80 587 (51%) 176 (51%) 132 (53%) 44 (47%)
 20–60 343 (30%) 100 (29%) 71 (28%) 29 (31%)
Pain score n.s.
 2–4 234 (20%) 71 (21%) 54 (22%) 17 (18%)
 5–7 550 (48%) 155 (45%) 116 (46%) 39 (42%)
 8–10 366 (32%) 117 (34%) 80 (32%) 37 (40%)
Visceral metastases n.s.
 No 838 (72%) 247 (72%) 178 (71%) 69 (74%)
 Yes 319 (28%) 96 (28%) 72 (29%) 24 (26%)
Systemic therapy 0.009
 No 531 (46%) 156 (46%) 103 (41%) 53 (57%)
 Yes 626 (54%) 187 (55%) 147 (59%) 40 (43%)
Treatment schedule n.s.
 1 × 8 Gy 578 (50%) 171 (50%) 129 (52%) 42 (45%)
 6 × 4 Gy 579 (50%) 172 (50%) 121 (48%) 51 (55%)
Pain medication n.s.
 No opioids 667 (58%) 170 (50%) 123 (49%) 47 (51%)
 Opioids 490 (42%) 173 (50%) 127 (51%) 46 (50%)
Spinal localization n.s.
 Thoracic spine 117 (34%) 90 (36%) 27 (29%)
 Thoraco-lumbar spine 32 (9%) 27 (11%) 5 (5%)
 Lumbar spine 183 (53%) 124 (50%) 59 (63%)
 Lumbo-sacral spine 11 (3%) 9 (4%) 2 (2%)

PA, Posterior-anterior field; APPA, Anterior-posterior and posterior-anterior field; KPS, Karnofsky performance score; Gy, Gray; n.s., not significant

aChi-square